Source: Annual Congress 2006 - COPD – therapy/exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. M. Lazic, V. B. Cupurdija, L. A. Novkovic, C. V. Ivan, O. M. Gajovic (Kragujevac, Serbia And Montenegro). Serum uric acid levels among patients with COPD exacerbations. Eur Respir J 2006; 28: Suppl. 50, 308

Member's Comments

No comment yet.

Related content which might interest you: Serum uric acid levels among COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 435s Year: 2003 Assessment of serum uric acid in COPD exacerbations Source: International Congress 2017 – Markers of COPD progression Year: 2017 Serum uric acid and uric acid/creatinine ratio in exacerbations of COPD Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Serum uric acid as a predictor of mortality and future exacerbations of COPD Source: Eur Respir J 2014; 43: 43-53 Year: 2004 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Serum ascorbic acid concentration in patients with acute pneumonia and in COPD patients with and without respiratory failure Source: Eur Respir J 2004; 24: Suppl. 48, 92s Year: 2004 Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations? Source: International Congress 2015 – COPD: interesting notes Year: 2015 Serum magnesium levels in acute exacerbation of COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007 Serum levels of hyaluronic acid are associated with COPD severity and predict survival Source: Eur Respir J, 53 (3) 1801183; 10.1183/13993003.01183-2018 Year: 2019 Serum ascorbid acid concentration in COPD patients with partial and with complete respiratory failure Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001 Blood plasma levels of ascorbic acid in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006 Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Serum lysophosphatidic acid levels and exacerbation frequency in chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Urinary uric acid excretion and overnight change in the urinary uric acid: creatinin ratio as a marker of tissue hypoxia in patients with COPD and OSA Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 Total serum bilirubin levels are not related to the severity of COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017